Serum iron level shortly after iron supplementation shortly after and 2 hours after meal in women with iron deficiency anemia

ABSTRACT Erna Kristin, Muhammad Hakimi, Sri Kadarsih Soejono, Lukman Hakim - Serum iron level shortly after iron supplementation shortly after and 2 hours after meal in women with iron deficiency anemia Background: Incidence of anemia in women in developing countries is still high, that is, around 4...

Full description

Bibliographic Details
Main Author: Perpustakaan UGM, i-lib
Format: Article
Published: [Yogyakarta] : Universitas Gadjah Mada 2009
Subjects:
Description
Summary:ABSTRACT Erna Kristin, Muhammad Hakimi, Sri Kadarsih Soejono, Lukman Hakim - Serum iron level shortly after iron supplementation shortly after and 2 hours after meal in women with iron deficiency anemia Background: Incidence of anemia in women in developing countries is still high, that is, around 43%. This incidence rate is far more hig'her that that in industrial countries, which is ranged between 10-12 %. The prevalence of iron deficiency anemia is still high, particularly in developing countries. The cause of the high prevalence of iron deficiency anemia is not known, since it involves various factors. Two of the probable etiologic factors is variability in dosage administration, and the effect of co-administered food. Studies on the pharmacokinetic 'of iron after single dose iron tablet administration in women with anemia and pharmacokinetic of iron coadministered with food in healthy women have been done, but study on repeated dose has never been conducted. Objective: To understand serum iron level after ingestion of repeated dose of iron shortly after and 2 hours after meal for 12 weeks in women with iron deficiency anemia. Method: The research design was a fase II clinical trial. Subjects were 24 women with iron deficiency anemia, classified into two groups, who were treated as follows: the first group was consisted of 12 women with iron deficiency anemia, treated with twice-a-day ferrous sulphate tablet @ 300 mg orally, given shortly after meal for 12 weeks